These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1947 related items for PubMed ID: 8509212

  • 1. Usage of T-cell receptor V beta chain genes in fresh and cultured tumor-infiltrating lymphocytes from human melanoma.
    Weidmann E, Elder EM, Trucco M, Lotze MT, Whiteside TL.
    Int J Cancer; 1993 May 28; 54(3):383-90. PubMed ID: 8509212
    [Abstract] [Full Text] [Related]

  • 2. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
    Sensi M, Salvi S, Castelli C, Maccalli C, Mazzocchi A, Mortarini R, Nicolini G, Herlyn M, Parmiani G, Anichini A.
    J Exp Med; 1993 Oct 01; 178(4):1231-46. PubMed ID: 8376931
    [Abstract] [Full Text] [Related]

  • 3. The T-cell receptor V beta gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma.
    Weidmann E, Whiteside TL, Giorda R, Herberman RB, Trucco M.
    Cancer Res; 1992 Nov 01; 52(21):5913-20. PubMed ID: 1382847
    [Abstract] [Full Text] [Related]

  • 4. Evidence for oligoclonal T-cell response in a metastasis of renal cell carcinoma responding to vaccination with autologous tumor cells and transfer of in vitro-sensitized vaccine-draining lymph node lymphocytes.
    Weidmann E, Logan TF, Yasumura S, Kirkwood JM, Trucco M, Whiteside TL.
    Cancer Res; 1993 Oct 15; 53(20):4745-9. PubMed ID: 8402652
    [Abstract] [Full Text] [Related]

  • 5. T cell receptor V beta 2 and V beta 6 mediate tumor-specific cytotoxicity by tumor-infiltrating lymphocytes in ovarian cancer.
    Peoples GE, Davey MP, Goedegebuure PS, Schoof DD, Eberlein TJ.
    J Immunol; 1993 Nov 15; 151(10):5472-80. PubMed ID: 8228239
    [Abstract] [Full Text] [Related]

  • 6. Analysis of T-cell receptor V region gene usage of cytotoxic T-lymphocytes and tumor-infiltrating lymphocytes derived from human autologous gastric signet ring cell carcinomas.
    Ikeda H, Sato N, Matsuura A, Kikuchi K.
    Cancer Res; 1993 Jul 01; 53(13):3078-84. PubMed ID: 8391386
    [Abstract] [Full Text] [Related]

  • 7. Skewed distribution of TCR V alpha 7-bearing T cells within tumor-infiltrating lymphocytes of HLA-A24(9)-positive patients with malignant glioma.
    Ebato M, Nitta T, Yagita H, Sato K, Okumura K.
    Immunol Lett; 1993 Dec 01; 39(1):53-64. PubMed ID: 8144191
    [Abstract] [Full Text] [Related]

  • 8. Effects of different culture protocols on the expression of discrete T-cell receptor variable regions in human tumour infiltrating lymphocytes.
    Filgueira L, Zuber M, Merlo A, Harder F, Heberer M, Spagnoli GC.
    Eur J Cancer; 1993 Dec 01; 29A(12):1754-60. PubMed ID: 8398305
    [Abstract] [Full Text] [Related]

  • 9. Preferential usage of T-cell receptor alpha beta variable regions among tumor-infiltrating lymphocytes in primary human malignant melanomas.
    Thor Straten P, Schøller J, Hou-Jensen K, Zeuthen J.
    Int J Cancer; 1994 Jan 02; 56(1):78-86. PubMed ID: 8262682
    [Abstract] [Full Text] [Related]

  • 10. Analysis of T cell receptor alpha beta variability in tumor-infiltrating lymphocytes in primary and metastatic melanoma.
    Zeuthen J, Birck A, Straten PT.
    Arch Immunol Ther Exp (Warsz); 1995 Jan 02; 43(2):123-33. PubMed ID: 8744727
    [Abstract] [Full Text] [Related]

  • 11. T-cell receptor repertoire in tumor-infiltrating lymphocytes. Analysis of melanoma-specific long-term lines.
    Nishimura MI, Kawakami Y, Charmley P, O'Neil B, Shilyansky J, Yannelli JR, Rosenberg SA, Hood L.
    J Immunother Emphasis Tumor Immunol; 1994 Aug 02; 16(2):85-94. PubMed ID: 7804531
    [Abstract] [Full Text] [Related]

  • 12. Expansion of major histocompatibility complex-restricted antimelanoma cytotoxic T-cell lymphocyte clones with identical T-cell receptor from tumor-infiltrating lymphocytes.
    Sensi M, Castelli C, Salvi S, Mazzocchi A, Mortarini R, Nicolini G, Anichini A, Parmiani G.
    J Immunother (1991); 1992 Oct 02; 12(3):207-11. PubMed ID: 1332745
    [Abstract] [Full Text] [Related]

  • 13. T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines.
    Shilyansky J, Nishimura MI, Yannelli JR, Kawakami Y, Jacknin LS, Charmley P, Rosenberg SA.
    Proc Natl Acad Sci U S A; 1994 Mar 29; 91(7):2829-33. PubMed ID: 7511820
    [Abstract] [Full Text] [Related]

  • 14. Analysis of T cell receptor alpha beta variability in lymphocytes infiltrating melanoma primary tumours and metastatic lesions.
    Schøller J, thor Straten P, Birck A, Siim E, Dahlström K, Drzewiecki KT, Zeuthen J.
    Cancer Immunol Immunother; 1994 Oct 29; 39(4):239-48. PubMed ID: 7954526
    [Abstract] [Full Text] [Related]

  • 15. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
    Baxevanis CN, Dedoussis GV, Papadopoulos NG, Missitzis I, Stathopoulos GP, Papamichail M.
    Cancer; 1994 Aug 15; 74(4):1275-82. PubMed ID: 7914469
    [Abstract] [Full Text] [Related]

  • 16. Human autologous tumor-specific T cells in malignant melanoma.
    Platsoucas CD.
    Cancer Metastasis Rev; 1991 Jun 15; 10(2):151-76. PubMed ID: 1873855
    [Abstract] [Full Text] [Related]

  • 17. Proliferative, phenotypic and functional and molecular characteristics of tumour-infiltrating lymphocytes obtained from unselected patients with malignant melanomas and expanded in vitro in the presence of recombinant interleukin-2.
    Melioli G, Guastella M, Semino C, Meta M, Pietra G, Ponte M, Queirolo P, Sertoli MR, Martini L, Reali UM.
    Melanoma Res; 1994 Apr 15; 4(2):127-33. PubMed ID: 8069098
    [Abstract] [Full Text] [Related]

  • 18. Direct transfer of a foreign MHC gene into human melanoma alters T cell receptor V beta usage by tumor-infiltrating lymphocytes.
    DeBruyne LA, Chang AE, Cameron MJ, Yang Z, Gordon D, Nabel EG, Nabel GJ, Bishop DK.
    Cancer Immunol Immunother; 1996 Sep 15; 43(1):49-58. PubMed ID: 8917636
    [Abstract] [Full Text] [Related]

  • 19. Phenotypic characterization of murine tumor-infiltrating T lymphocytes.
    Karpati RM, Banks SM, Malissen B, Rosenberg SA, Sheard MA, Weber JS, Hodes RJ.
    J Immunol; 1991 Mar 15; 146(6):2043-51. PubMed ID: 1672340
    [Abstract] [Full Text] [Related]

  • 20. HLA restriction and T-cell-receptor V beta gene expression of cytotoxic T lymphocytes reactive with human squamous-cell carcinoma of the head and neck.
    Yasumura S, Weidmann E, Hirabayashi H, Johnson JT, Herberman RB, Whiteside TL.
    Int J Cancer; 1994 May 01; 57(3):297-305. PubMed ID: 8168988
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 98.